Gregory J. Anderson

QIMR Berghofer Medical Research Institute, George Mason University

Papers

Total Citations

1,515

H-Index

About

Gregory J. Anderson is a pioneering researcher at the intersection of nanomedicine and human-robot interaction. His most celebrated contribution is the development of a DNA nanorobot that functions as a cancer therapeutic in response to a molecular trigger in vivo. This groundbreaking work, published in 2018 and amassing over 1,480 citations, demonstrates how programmable DNA structures can deliver targeted treatments directly to tumors, opening new frontiers in precision medicine. In parallel, Anderson has explored the social dynamics of human-robot communication. His studies on robot-directed speech, including a 2010 paper with 26 citations, investigate how first-time users conceptualize and speak to robots, revealing critical insights for designing intuitive, natural language interfaces. By bridging molecular engineering and cognitive robotics, Anderson’s work addresses both the biological and behavioral challenges of emerging technologies. His dual focus on life-saving nanotherapeutics and user-centered robot design underscores a commitment to translating complex science into real-world impact. For students and researchers, Anderson exemplifies how interdisciplinary thinking can drive innovation—from the nanoscale to everyday human interaction.